Growth Drivers
Proliferating Cancer and Diabetic Diseases To Drive the Market Growth
Increment in diseases such as cancer and diabetes are the major factor fueling the market. According to the World Health Organization, one in every 5 men and one in every 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Additionally, continuous technological advancements, rising research & development expenditure by pharmaceutical companies, rising funding through government bodies, and availability of products to conduct protocol with high specificity and sensitivity are anticipated to drive the market over the forecast period.
Restraints
High Production Cost Hindering the Global Market
The market is anticipated to be hindered by factors such as high production cost owing to the fluctuating prices of raw materials that are required for the manufacturing of glycomics/glycobiology, coupled with the low availability of skilled professionals that raises the overall operational expenses of the manufacturers operating in the market.
Base Year |
2023 |
Forecast Year |
2024–2036 |
CAGR |
13.2% |
Base Year Market Size (2023) |
USD 1.71 billion |
Forecast Year Market Size (2036) |
USD 8.57 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?